Global Hematopoietic Agents Production, Demand and Key Producers, 2022-2028
Hematopoiesis is the formation of blood in the body. It is the complex process of proliferation, differentiation and maturation of the cellular components that is erythrocytes, platelets and leucocytes from the bone marrow stem cells. The balanced interaction between the endogenously derived hematopoietic growth factor and exogenously supplied important nutrients such as hematinics regulates the hematopoiesis process.
This report studies the global Hematopoietic Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hematopoietic Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematopoietic Agents that contribute to its increasing demand across many markets.
The global Hematopoietic Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Hematopoietic Agents total production and demand, 2017-2028, (K Units)
Global Hematopoietic Agents total production value, 2017-2028, (USD Million)
Global Hematopoietic Agents production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Hematopoietic Agents consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Hematopoietic Agents domestic production, consumption, key domestic manufacturers and share
Global Hematopoietic Agents production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Hematopoietic Agents production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Hematopoietic Agents production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Hematopoietic Agents market based on the following parameters – headquarters, production locations, products portfolio, Hematopoietic Agents revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematopoietic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Hematopoietic Agents Market, By Region:
1. How big is the global Hematopoietic Agents market?
2. What is the demand of the global Hematopoietic Agents market?
3. What is the year over year growth of the global Hematopoietic Agents market?
4. What is the production and production value of the global Hematopoietic Agents market?
5. Who are the key producers in the global Hematopoietic Agents market?
6. What are the growth factors driving the market demand?
This report studies the global Hematopoietic Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hematopoietic Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hematopoietic Agents that contribute to its increasing demand across many markets.
The global Hematopoietic Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Hematopoietic Agents total production and demand, 2017-2028, (K Units)
Global Hematopoietic Agents total production value, 2017-2028, (USD Million)
Global Hematopoietic Agents production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Hematopoietic Agents consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Hematopoietic Agents domestic production, consumption, key domestic manufacturers and share
Global Hematopoietic Agents production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Hematopoietic Agents production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Hematopoietic Agents production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Hematopoietic Agents market based on the following parameters – headquarters, production locations, products portfolio, Hematopoietic Agents revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hematopoietic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Hematopoietic Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Oral
- Injection
- Anemia
- Hematopoietic Growth Factor Disorder
- Other
- F. Hoffmann-La Roche Ltd
- Mylan N.V
- Teva Pharmaceutical Industries Ltd
- Sanofi
- Pfizer Inc
- GSK plc
- Novartis AG
- Bayer AG
- Merck & Co., Inc
- AbbVie Inc
- Sun Pharmaceutical Industries Ltd
- Aurobindo Pharma
- Lupin
- Hikma Pharmaceuticals PLC
- PHARMACOSMOS A/S
- Akebia Therapeutics, Inc
1. How big is the global Hematopoietic Agents market?
2. What is the demand of the global Hematopoietic Agents market?
3. What is the year over year growth of the global Hematopoietic Agents market?
4. What is the production and production value of the global Hematopoietic Agents market?
5. Who are the key producers in the global Hematopoietic Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hematopoietic Agents Introduction
1.2 World Hematopoietic Agents Supply & Forecast
1.2.1 World Hematopoietic Agents Production Value (2017 & 2021 & 2028)
1.2.2 World Hematopoietic Agents Production (2017-2028)
1.2.3 World Hematopoietic Agents Pricing Trends (2017-2028)
1.3 World Hematopoietic Agents Production by Region
1.3.1 World Hematopoietic Agents Production Value by Region (2017-2028)
1.3.2 World Hematopoietic Agents Production by Region (2017-2028)
1.3.3 World Hematopoietic Agents Average Price by Region (2017-2028)
1.3.4 North America Hematopoietic Agents Production (2017-2028)
1.3.5 Europe Hematopoietic Agents Production (2017-2028)
1.3.6 China Hematopoietic Agents Production (2017-2028)
1.3.7 Japan Hematopoietic Agents Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematopoietic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematopoietic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hematopoietic Agents Demand (2017-2028)
2.2 World Hematopoietic Agents Consumption by Region
2.2.1 World Hematopoietic Agents Consumption by Region (2017-2022)
2.2.2 World Hematopoietic Agents Consumption Forecast by Region (2023-2028)
2.3 United States Hematopoietic Agents Consumption (2017-2028)
2.4 China Hematopoietic Agents Consumption (2017-2028)
2.5 Europe Hematopoietic Agents Consumption (2017-2028)
2.6 Japan Hematopoietic Agents Consumption (2017-2028)
2.7 South Korea Hematopoietic Agents Consumption (2017-2028)
2.8 ASEAN Hematopoietic Agents Consumption (2017-2028)
2.9 India Hematopoietic Agents Consumption (2017-2028)
3 WORLD HEMATOPOIETIC AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hematopoietic Agents Production Value by Manufacturer (2017-2022)
3.2 World Hematopoietic Agents Production by Manufacturer (2017-2022)
3.3 World Hematopoietic Agents Average Price by Manufacturer (2017-2022)
3.4 Hematopoietic Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hematopoietic Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hematopoietic Agents in 2021
3.5.3 Global Concentration Ratios (CR8) for Hematopoietic Agents in 2021
3.6 Hematopoietic Agents Market: Overall Company Footprint Analysis
3.6.1 Hematopoietic Agents Market: Region Footprint
3.6.2 Hematopoietic Agents Market: Company Product Type Footprint
3.6.3 Hematopoietic Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hematopoietic Agents Production Value Comparison
4.1.1 United States VS China: Hematopoietic Agents Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Hematopoietic Agents Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Hematopoietic Agents Production Comparison
4.2.1 United States VS China: Hematopoietic Agents Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Hematopoietic Agents Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Hematopoietic Agents Consumption Comparison
4.3.1 United States VS China: Hematopoietic Agents Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Hematopoietic Agents Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Hematopoietic Agents in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
4.5 China Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Hematopoietic Agents in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Hematopoietic Agents in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Hematopoietic Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Hematopoietic Agents Production by Type (2017-2028)
5.3.2 World Hematopoietic Agents Production Value by Type (2017-2028)
5.3.3 World Hematopoietic Agents Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hematopoietic Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Anemia
6.2.2 Hematopoietic Growth Factor Disorder
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hematopoietic Agents Production by Application (2017-2028)
6.3.2 World Hematopoietic Agents Production Value by Application (2017-2028)
6.3.3 World Hematopoietic Agents Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Hematopoietic Agents Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Hematopoietic Agents Product and Services
7.2.4 Mylan N.V Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Hematopoietic Agents Product and Services
7.4.4 Sanofi Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Hematopoietic Agents Product and Services
7.5.4 Pfizer Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GSK plc
7.6.1 GSK plc Details
7.6.2 GSK plc Major Business
7.6.3 GSK plc Hematopoietic Agents Product and Services
7.6.4 GSK plc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 GSK plc Recent Developments/Updates
7.6.6 GSK plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Hematopoietic Agents Product and Services
7.7.4 Novartis AG Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Bayer AG
7.8.1 Bayer AG Details
7.8.2 Bayer AG Major Business
7.8.3 Bayer AG Hematopoietic Agents Product and Services
7.8.4 Bayer AG Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bayer AG Recent Developments/Updates
7.8.6 Bayer AG Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc
7.9.1 Merck & Co., Inc Details
7.9.2 Merck & Co., Inc Major Business
7.9.3 Merck & Co., Inc Hematopoietic Agents Product and Services
7.9.4 Merck & Co., Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck & Co., Inc Recent Developments/Updates
7.9.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.10 AbbVie Inc
7.10.1 AbbVie Inc Details
7.10.2 AbbVie Inc Major Business
7.10.3 AbbVie Inc Hematopoietic Agents Product and Services
7.10.4 AbbVie Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 AbbVie Inc Recent Developments/Updates
7.10.6 AbbVie Inc Competitive Strengths & Weaknesses
7.11 Sun Pharmaceutical Industries Ltd
7.11.1 Sun Pharmaceutical Industries Ltd Details
7.11.2 Sun Pharmaceutical Industries Ltd Major Business
7.11.3 Sun Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
7.11.4 Sun Pharmaceutical Industries Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.11.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Details
7.12.2 Aurobindo Pharma Major Business
7.12.3 Aurobindo Pharma Hematopoietic Agents Product and Services
7.12.4 Aurobindo Pharma Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Aurobindo Pharma Recent Developments/Updates
7.12.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.13 Lupin
7.13.1 Lupin Details
7.13.2 Lupin Major Business
7.13.3 Lupin Hematopoietic Agents Product and Services
7.13.4 Lupin Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Lupin Recent Developments/Updates
7.13.6 Lupin Competitive Strengths & Weaknesses
7.14 Hikma Pharmaceuticals PLC
7.14.1 Hikma Pharmaceuticals PLC Details
7.14.2 Hikma Pharmaceuticals PLC Major Business
7.14.3 Hikma Pharmaceuticals PLC Hematopoietic Agents Product and Services
7.14.4 Hikma Pharmaceuticals PLC Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
7.14.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
7.15 PHARMACOSMOS A/S
7.15.1 PHARMACOSMOS A/S Details
7.15.2 PHARMACOSMOS A/S Major Business
7.15.3 PHARMACOSMOS A/S Hematopoietic Agents Product and Services
7.15.4 PHARMACOSMOS A/S Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 PHARMACOSMOS A/S Recent Developments/Updates
7.15.6 PHARMACOSMOS A/S Competitive Strengths & Weaknesses
7.16 Akebia Therapeutics, Inc
7.16.1 Akebia Therapeutics, Inc Details
7.16.2 Akebia Therapeutics, Inc Major Business
7.16.3 Akebia Therapeutics, Inc Hematopoietic Agents Product and Services
7.16.4 Akebia Therapeutics, Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Akebia Therapeutics, Inc Recent Developments/Updates
7.16.6 Akebia Therapeutics, Inc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Hematopoietic Agents and Key Manufacturers
8.2 Hematopoietic Agents Manufacturing Costs
8.3 Hematopoietic Agents Production Process
8.4 Hematopoietic Agents Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Hematopoietic Agents Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Hematopoietic Agents Typical Distributors
9.3 Hematopoietic Agents Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Hematopoietic Agents Introduction
1.2 World Hematopoietic Agents Supply & Forecast
1.2.1 World Hematopoietic Agents Production Value (2017 & 2021 & 2028)
1.2.2 World Hematopoietic Agents Production (2017-2028)
1.2.3 World Hematopoietic Agents Pricing Trends (2017-2028)
1.3 World Hematopoietic Agents Production by Region
1.3.1 World Hematopoietic Agents Production Value by Region (2017-2028)
1.3.2 World Hematopoietic Agents Production by Region (2017-2028)
1.3.3 World Hematopoietic Agents Average Price by Region (2017-2028)
1.3.4 North America Hematopoietic Agents Production (2017-2028)
1.3.5 Europe Hematopoietic Agents Production (2017-2028)
1.3.6 China Hematopoietic Agents Production (2017-2028)
1.3.7 Japan Hematopoietic Agents Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hematopoietic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hematopoietic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hematopoietic Agents Demand (2017-2028)
2.2 World Hematopoietic Agents Consumption by Region
2.2.1 World Hematopoietic Agents Consumption by Region (2017-2022)
2.2.2 World Hematopoietic Agents Consumption Forecast by Region (2023-2028)
2.3 United States Hematopoietic Agents Consumption (2017-2028)
2.4 China Hematopoietic Agents Consumption (2017-2028)
2.5 Europe Hematopoietic Agents Consumption (2017-2028)
2.6 Japan Hematopoietic Agents Consumption (2017-2028)
2.7 South Korea Hematopoietic Agents Consumption (2017-2028)
2.8 ASEAN Hematopoietic Agents Consumption (2017-2028)
2.9 India Hematopoietic Agents Consumption (2017-2028)
3 WORLD HEMATOPOIETIC AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hematopoietic Agents Production Value by Manufacturer (2017-2022)
3.2 World Hematopoietic Agents Production by Manufacturer (2017-2022)
3.3 World Hematopoietic Agents Average Price by Manufacturer (2017-2022)
3.4 Hematopoietic Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hematopoietic Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hematopoietic Agents in 2021
3.5.3 Global Concentration Ratios (CR8) for Hematopoietic Agents in 2021
3.6 Hematopoietic Agents Market: Overall Company Footprint Analysis
3.6.1 Hematopoietic Agents Market: Region Footprint
3.6.2 Hematopoietic Agents Market: Company Product Type Footprint
3.6.3 Hematopoietic Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hematopoietic Agents Production Value Comparison
4.1.1 United States VS China: Hematopoietic Agents Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Hematopoietic Agents Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Hematopoietic Agents Production Comparison
4.2.1 United States VS China: Hematopoietic Agents Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Hematopoietic Agents Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Hematopoietic Agents Consumption Comparison
4.3.1 United States VS China: Hematopoietic Agents Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Hematopoietic Agents Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Hematopoietic Agents in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
4.5 China Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Hematopoietic Agents in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Hematopoietic Agents Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Hematopoietic Agents in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Hematopoietic Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Hematopoietic Agents Production by Type (2017-2028)
5.3.2 World Hematopoietic Agents Production Value by Type (2017-2028)
5.3.3 World Hematopoietic Agents Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hematopoietic Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Anemia
6.2.2 Hematopoietic Growth Factor Disorder
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hematopoietic Agents Production by Application (2017-2028)
6.3.2 World Hematopoietic Agents Production Value by Application (2017-2028)
6.3.3 World Hematopoietic Agents Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Details
7.1.2 F. Hoffmann-La Roche Ltd Major Business
7.1.3 F. Hoffmann-La Roche Ltd Hematopoietic Agents Product and Services
7.1.4 F. Hoffmann-La Roche Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.1.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Hematopoietic Agents Product and Services
7.2.4 Mylan N.V Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Details
7.3.2 Teva Pharmaceutical Industries Ltd Major Business
7.3.3 Teva Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
7.3.4 Teva Pharmaceutical Industries Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.3.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Hematopoietic Agents Product and Services
7.4.4 Sanofi Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer Inc
7.5.1 Pfizer Inc Details
7.5.2 Pfizer Inc Major Business
7.5.3 Pfizer Inc Hematopoietic Agents Product and Services
7.5.4 Pfizer Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Pfizer Inc Recent Developments/Updates
7.5.6 Pfizer Inc Competitive Strengths & Weaknesses
7.6 GSK plc
7.6.1 GSK plc Details
7.6.2 GSK plc Major Business
7.6.3 GSK plc Hematopoietic Agents Product and Services
7.6.4 GSK plc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 GSK plc Recent Developments/Updates
7.6.6 GSK plc Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG Hematopoietic Agents Product and Services
7.7.4 Novartis AG Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Bayer AG
7.8.1 Bayer AG Details
7.8.2 Bayer AG Major Business
7.8.3 Bayer AG Hematopoietic Agents Product and Services
7.8.4 Bayer AG Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bayer AG Recent Developments/Updates
7.8.6 Bayer AG Competitive Strengths & Weaknesses
7.9 Merck & Co., Inc
7.9.1 Merck & Co., Inc Details
7.9.2 Merck & Co., Inc Major Business
7.9.3 Merck & Co., Inc Hematopoietic Agents Product and Services
7.9.4 Merck & Co., Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Merck & Co., Inc Recent Developments/Updates
7.9.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.10 AbbVie Inc
7.10.1 AbbVie Inc Details
7.10.2 AbbVie Inc Major Business
7.10.3 AbbVie Inc Hematopoietic Agents Product and Services
7.10.4 AbbVie Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 AbbVie Inc Recent Developments/Updates
7.10.6 AbbVie Inc Competitive Strengths & Weaknesses
7.11 Sun Pharmaceutical Industries Ltd
7.11.1 Sun Pharmaceutical Industries Ltd Details
7.11.2 Sun Pharmaceutical Industries Ltd Major Business
7.11.3 Sun Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
7.11.4 Sun Pharmaceutical Industries Ltd Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.11.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Details
7.12.2 Aurobindo Pharma Major Business
7.12.3 Aurobindo Pharma Hematopoietic Agents Product and Services
7.12.4 Aurobindo Pharma Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Aurobindo Pharma Recent Developments/Updates
7.12.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.13 Lupin
7.13.1 Lupin Details
7.13.2 Lupin Major Business
7.13.3 Lupin Hematopoietic Agents Product and Services
7.13.4 Lupin Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Lupin Recent Developments/Updates
7.13.6 Lupin Competitive Strengths & Weaknesses
7.14 Hikma Pharmaceuticals PLC
7.14.1 Hikma Pharmaceuticals PLC Details
7.14.2 Hikma Pharmaceuticals PLC Major Business
7.14.3 Hikma Pharmaceuticals PLC Hematopoietic Agents Product and Services
7.14.4 Hikma Pharmaceuticals PLC Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
7.14.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
7.15 PHARMACOSMOS A/S
7.15.1 PHARMACOSMOS A/S Details
7.15.2 PHARMACOSMOS A/S Major Business
7.15.3 PHARMACOSMOS A/S Hematopoietic Agents Product and Services
7.15.4 PHARMACOSMOS A/S Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 PHARMACOSMOS A/S Recent Developments/Updates
7.15.6 PHARMACOSMOS A/S Competitive Strengths & Weaknesses
7.16 Akebia Therapeutics, Inc
7.16.1 Akebia Therapeutics, Inc Details
7.16.2 Akebia Therapeutics, Inc Major Business
7.16.3 Akebia Therapeutics, Inc Hematopoietic Agents Product and Services
7.16.4 Akebia Therapeutics, Inc Hematopoietic Agents Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Akebia Therapeutics, Inc Recent Developments/Updates
7.16.6 Akebia Therapeutics, Inc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Hematopoietic Agents and Key Manufacturers
8.2 Hematopoietic Agents Manufacturing Costs
8.3 Hematopoietic Agents Production Process
8.4 Hematopoietic Agents Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Hematopoietic Agents Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Hematopoietic Agents Typical Distributors
9.3 Hematopoietic Agents Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Hematopoietic Agents Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Hematopoietic Agents Production Value by Region (2017-2022) & (USD Million)
Table 3. World Hematopoietic Agents Production Value by Region (2023-2028) & (USD Million)
Table 4. World Hematopoietic Agents Production Value Market Share by Region (2017-2022)
Table 5. World Hematopoietic Agents Production Value Market Share by Region (2023-2028)
Table 6. World Hematopoietic Agents Production by Region (2017-2022) & (K Units)
Table 7. World Hematopoietic Agents Production by Region (2023-2028) & (K Units)
Table 8. World Hematopoietic Agents Production Market Share by Region (2017-2022)
Table 9. World Hematopoietic Agents Production Market Share by Region (2023-2028)
Table 10. World Hematopoietic Agents Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Hematopoietic Agents Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Hematopoietic Agents Major Market Trends
Table 13. World Hematopoietic Agents Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Hematopoietic Agents Consumption by Region (2017-2022) & (K Units)
Table 15. World Hematopoietic Agents Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Hematopoietic Agents Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Hematopoietic Agents Producers in 2021
Table 18. World Hematopoietic Agents Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Hematopoietic Agents Producers in 2021
Table 20. World Hematopoietic Agents Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Hematopoietic Agents Company Evaluation Quadrant
Table 22. World Hematopoietic Agents Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Hematopoietic Agents Production Site of Key Manufacturer
Table 24. Hematopoietic Agents Market: Company Product Type Footprint
Table 25. Hematopoietic Agents Market: Company Product Application Footprint
Table 26. Hematopoietic Agents Competitive Factors
Table 27. Hematopoietic Agents New Entrant and Capacity Expansion Plans
Table 28. Hematopoietic Agents Mergers & Acquisitions Activity
Table 29. United States VS China Hematopoietic Agents Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Hematopoietic Agents Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Hematopoietic Agents Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Hematopoietic Agents in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Hematopoietic Agents in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Hematopoietic Agents in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Hematopoietic Agents Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Hematopoietic Agents Production by Type (2017-2022) & (K Units)
Table 49. World Hematopoietic Agents Production by Type (2023-2028) & (K Units)
Table 50. World Hematopoietic Agents Production Value by Type (2017-2022) & (USD Million)
Table 51. World Hematopoietic Agents Production Value by Type (2023-2028) & (USD Million)
Table 52. World Hematopoietic Agents Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Hematopoietic Agents Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Hematopoietic Agents Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Hematopoietic Agents Production by Application (2017-2022) & (K Units)
Table 56. World Hematopoietic Agents Production by Application (2023-2028) & (K Units)
Table 57. World Hematopoietic Agents Production Value by Application (2017-2022) & (USD Million)
Table 58. World Hematopoietic Agents Production Value by Application (2023-2028) & (USD Million)
Table 59. World Hematopoietic Agents Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Hematopoietic Agents Average Price by Application (2023-2028) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Hematopoietic Agents Product and Services
Table 64. F. Hoffmann-La Roche Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Hematopoietic Agents Product and Services
Table 70. Mylan N.V Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Hematopoietic Agents Product and Services
Table 82. Sanofi Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Hematopoietic Agents Product and Services
Table 88. Pfizer Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GSK plc Basic Information, Manufacturing Base and Competitors
Table 92. GSK plc Major Business
Table 93. GSK plc Hematopoietic Agents Product and Services
Table 94. GSK plc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. GSK plc Recent Developments/Updates
Table 96. GSK plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Hematopoietic Agents Product and Services
Table 100. Novartis AG Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 104. Bayer AG Major Business
Table 105. Bayer AG Hematopoietic Agents Product and Services
Table 106. Bayer AG Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bayer AG Recent Developments/Updates
Table 108. Bayer AG Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc Major Business
Table 111. Merck & Co., Inc Hematopoietic Agents Product and Services
Table 112. Merck & Co., Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck & Co., Inc Recent Developments/Updates
Table 114. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 115. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 116. AbbVie Inc Major Business
Table 117. AbbVie Inc Hematopoietic Agents Product and Services
Table 118. AbbVie Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. AbbVie Inc Recent Developments/Updates
Table 120. AbbVie Inc Competitive Strengths & Weaknesses
Table 121. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Sun Pharmaceutical Industries Ltd Major Business
Table 123. Sun Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
Table 124. Sun Pharmaceutical Industries Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 126. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 127. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Aurobindo Pharma Major Business
Table 129. Aurobindo Pharma Hematopoietic Agents Product and Services
Table 130. Aurobindo Pharma Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Aurobindo Pharma Recent Developments/Updates
Table 132. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 133. Lupin Basic Information, Manufacturing Base and Competitors
Table 134. Lupin Major Business
Table 135. Lupin Hematopoietic Agents Product and Services
Table 136. Lupin Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Lupin Recent Developments/Updates
Table 138. Lupin Competitive Strengths & Weaknesses
Table 139. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 140. Hikma Pharmaceuticals PLC Major Business
Table 141. Hikma Pharmaceuticals PLC Hematopoietic Agents Product and Services
Table 142. Hikma Pharmaceuticals PLC Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 144. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 145. PHARMACOSMOS A/S Basic Information, Manufacturing Base and Competitors
Table 146. PHARMACOSMOS A/S Major Business
Table 147. PHARMACOSMOS A/S Hematopoietic Agents Product and Services
Table 148. PHARMACOSMOS A/S Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. PHARMACOSMOS A/S Recent Developments/Updates
Table 150. Akebia Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 151. Akebia Therapeutics, Inc Major Business
Table 152. Akebia Therapeutics, Inc Hematopoietic Agents Product and Services
Table 153. Akebia Therapeutics, Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Hematopoietic Agents Raw Material
Table 155. Key Manufacturers of Hematopoietic Agents Raw Materials
Table 156. Hematopoietic Agents Typical Distributors
Table 157. Hematopoietic Agents Typical Customers
Table 1. World Hematopoietic Agents Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Hematopoietic Agents Production Value by Region (2017-2022) & (USD Million)
Table 3. World Hematopoietic Agents Production Value by Region (2023-2028) & (USD Million)
Table 4. World Hematopoietic Agents Production Value Market Share by Region (2017-2022)
Table 5. World Hematopoietic Agents Production Value Market Share by Region (2023-2028)
Table 6. World Hematopoietic Agents Production by Region (2017-2022) & (K Units)
Table 7. World Hematopoietic Agents Production by Region (2023-2028) & (K Units)
Table 8. World Hematopoietic Agents Production Market Share by Region (2017-2022)
Table 9. World Hematopoietic Agents Production Market Share by Region (2023-2028)
Table 10. World Hematopoietic Agents Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Hematopoietic Agents Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Hematopoietic Agents Major Market Trends
Table 13. World Hematopoietic Agents Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Hematopoietic Agents Consumption by Region (2017-2022) & (K Units)
Table 15. World Hematopoietic Agents Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Hematopoietic Agents Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Hematopoietic Agents Producers in 2021
Table 18. World Hematopoietic Agents Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Hematopoietic Agents Producers in 2021
Table 20. World Hematopoietic Agents Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Hematopoietic Agents Company Evaluation Quadrant
Table 22. World Hematopoietic Agents Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Hematopoietic Agents Production Site of Key Manufacturer
Table 24. Hematopoietic Agents Market: Company Product Type Footprint
Table 25. Hematopoietic Agents Market: Company Product Application Footprint
Table 26. Hematopoietic Agents Competitive Factors
Table 27. Hematopoietic Agents New Entrant and Capacity Expansion Plans
Table 28. Hematopoietic Agents Mergers & Acquisitions Activity
Table 29. United States VS China Hematopoietic Agents Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Hematopoietic Agents Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Hematopoietic Agents Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Hematopoietic Agents in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Hematopoietic Agents in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Hematopoietic Agents in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Hematopoietic Agents Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Hematopoietic Agents Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Hematopoietic Agents Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Hematopoietic Agents Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Hematopoietic Agents Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Hematopoietic Agents Production by Type (2017-2022) & (K Units)
Table 49. World Hematopoietic Agents Production by Type (2023-2028) & (K Units)
Table 50. World Hematopoietic Agents Production Value by Type (2017-2022) & (USD Million)
Table 51. World Hematopoietic Agents Production Value by Type (2023-2028) & (USD Million)
Table 52. World Hematopoietic Agents Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Hematopoietic Agents Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Hematopoietic Agents Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Hematopoietic Agents Production by Application (2017-2022) & (K Units)
Table 56. World Hematopoietic Agents Production by Application (2023-2028) & (K Units)
Table 57. World Hematopoietic Agents Production Value by Application (2017-2022) & (USD Million)
Table 58. World Hematopoietic Agents Production Value by Application (2023-2028) & (USD Million)
Table 59. World Hematopoietic Agents Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Hematopoietic Agents Average Price by Application (2023-2028) & (US$/Unit)
Table 61. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 62. F. Hoffmann-La Roche Ltd Major Business
Table 63. F. Hoffmann-La Roche Ltd Hematopoietic Agents Product and Services
Table 64. F. Hoffmann-La Roche Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 66. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Hematopoietic Agents Product and Services
Table 70. Mylan N.V Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Industries Ltd Major Business
Table 75. Teva Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
Table 76. Teva Pharmaceutical Industries Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 78. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Hematopoietic Agents Product and Services
Table 82. Sanofi Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc Major Business
Table 87. Pfizer Inc Hematopoietic Agents Product and Services
Table 88. Pfizer Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Pfizer Inc Recent Developments/Updates
Table 90. Pfizer Inc Competitive Strengths & Weaknesses
Table 91. GSK plc Basic Information, Manufacturing Base and Competitors
Table 92. GSK plc Major Business
Table 93. GSK plc Hematopoietic Agents Product and Services
Table 94. GSK plc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. GSK plc Recent Developments/Updates
Table 96. GSK plc Competitive Strengths & Weaknesses
Table 97. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 98. Novartis AG Major Business
Table 99. Novartis AG Hematopoietic Agents Product and Services
Table 100. Novartis AG Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Novartis AG Recent Developments/Updates
Table 102. Novartis AG Competitive Strengths & Weaknesses
Table 103. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 104. Bayer AG Major Business
Table 105. Bayer AG Hematopoietic Agents Product and Services
Table 106. Bayer AG Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bayer AG Recent Developments/Updates
Table 108. Bayer AG Competitive Strengths & Weaknesses
Table 109. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co., Inc Major Business
Table 111. Merck & Co., Inc Hematopoietic Agents Product and Services
Table 112. Merck & Co., Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Merck & Co., Inc Recent Developments/Updates
Table 114. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 115. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 116. AbbVie Inc Major Business
Table 117. AbbVie Inc Hematopoietic Agents Product and Services
Table 118. AbbVie Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. AbbVie Inc Recent Developments/Updates
Table 120. AbbVie Inc Competitive Strengths & Weaknesses
Table 121. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Sun Pharmaceutical Industries Ltd Major Business
Table 123. Sun Pharmaceutical Industries Ltd Hematopoietic Agents Product and Services
Table 124. Sun Pharmaceutical Industries Ltd Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 126. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 127. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Aurobindo Pharma Major Business
Table 129. Aurobindo Pharma Hematopoietic Agents Product and Services
Table 130. Aurobindo Pharma Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Aurobindo Pharma Recent Developments/Updates
Table 132. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 133. Lupin Basic Information, Manufacturing Base and Competitors
Table 134. Lupin Major Business
Table 135. Lupin Hematopoietic Agents Product and Services
Table 136. Lupin Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Lupin Recent Developments/Updates
Table 138. Lupin Competitive Strengths & Weaknesses
Table 139. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 140. Hikma Pharmaceuticals PLC Major Business
Table 141. Hikma Pharmaceuticals PLC Hematopoietic Agents Product and Services
Table 142. Hikma Pharmaceuticals PLC Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 144. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 145. PHARMACOSMOS A/S Basic Information, Manufacturing Base and Competitors
Table 146. PHARMACOSMOS A/S Major Business
Table 147. PHARMACOSMOS A/S Hematopoietic Agents Product and Services
Table 148. PHARMACOSMOS A/S Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. PHARMACOSMOS A/S Recent Developments/Updates
Table 150. Akebia Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 151. Akebia Therapeutics, Inc Major Business
Table 152. Akebia Therapeutics, Inc Hematopoietic Agents Product and Services
Table 153. Akebia Therapeutics, Inc Hematopoietic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Hematopoietic Agents Raw Material
Table 155. Key Manufacturers of Hematopoietic Agents Raw Materials
Table 156. Hematopoietic Agents Typical Distributors
Table 157. Hematopoietic Agents Typical Customers
LIST OF FIGURES
Figure 1. Hematopoietic Agents Picture
Figure 2. World Hematopoietic Agents Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Hematopoietic Agents Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 5. World Hematopoietic Agents Average Price (2017-2028) & (US$/Unit)
Figure 6. World Hematopoietic Agents Production Value Market Share by Region (2017-2028)
Figure 7. World Hematopoietic Agents Production Market Share by Region (2017-2028)
Figure 8. North America Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 9. Europe Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 10. China Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 11. Japan Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 12. Hematopoietic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hematopoietic Agents Demand (2017-2028) & (K Units)
Figure 15. World Hematopoietic Agents Consumption Market Share by Region (2017-2028)
Figure 16. United States Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 17. China Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 18. Europe Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 19. Japan Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 20. South Korea Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 22. India Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Hematopoietic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hematopoietic Agents Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hematopoietic Agents Markets in 2021
Figure 26. United States VS China: Hematopoietic Agents Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Hematopoietic Agents Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Hematopoietic Agents Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Hematopoietic Agents in United States
Figure 30. Key Producers and Market Share of Hematopoietic Agents in China
Figure 31. Key Producers and Market Share of Hematopoietic Agents in Rest of World
Figure 32. World Hematopoietic Agents Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Hematopoietic Agents Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Injection
Figure 36. World Hematopoietic Agents Production Market Share by Type (2017-2028)
Figure 37. World Hematopoietic Agents Production Value Market Share by Type (2017-2028)
Figure 38. World Hematopoietic Agents Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Hematopoietic Agents Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Hematopoietic Agents Production Value Market Share by Application in 2021
Figure 41. Anemia
Figure 42. Hematopoietic Growth Factor Disorder
Figure 43. Other
Figure 44. World Hematopoietic Agents Production Market Share by Application (2017-2028)
Figure 45. World Hematopoietic Agents Production Value Market Share by Application (2017-2028)
Figure 46. World Hematopoietic Agents Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Hematopoietic Agents in 2021
Figure 48. Manufacturing Process Analysis of Hematopoietic Agents
Figure 49. Hematopoietic Agents Industrial Chain
Figure 50. Distribution Channel Breakdown for Hematopoietic Agents Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Hematopoietic Agents Picture
Figure 2. World Hematopoietic Agents Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Hematopoietic Agents Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 5. World Hematopoietic Agents Average Price (2017-2028) & (US$/Unit)
Figure 6. World Hematopoietic Agents Production Value Market Share by Region (2017-2028)
Figure 7. World Hematopoietic Agents Production Market Share by Region (2017-2028)
Figure 8. North America Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 9. Europe Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 10. China Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 11. Japan Hematopoietic Agents Production (2017-2028) & (K Units)
Figure 12. Hematopoietic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hematopoietic Agents Demand (2017-2028) & (K Units)
Figure 15. World Hematopoietic Agents Consumption Market Share by Region (2017-2028)
Figure 16. United States Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 17. China Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 18. Europe Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 19. Japan Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 20. South Korea Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 22. India Hematopoietic Agents Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Hematopoietic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hematopoietic Agents Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hematopoietic Agents Markets in 2021
Figure 26. United States VS China: Hematopoietic Agents Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Hematopoietic Agents Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Hematopoietic Agents Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Hematopoietic Agents in United States
Figure 30. Key Producers and Market Share of Hematopoietic Agents in China
Figure 31. Key Producers and Market Share of Hematopoietic Agents in Rest of World
Figure 32. World Hematopoietic Agents Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Hematopoietic Agents Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Injection
Figure 36. World Hematopoietic Agents Production Market Share by Type (2017-2028)
Figure 37. World Hematopoietic Agents Production Value Market Share by Type (2017-2028)
Figure 38. World Hematopoietic Agents Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Hematopoietic Agents Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Hematopoietic Agents Production Value Market Share by Application in 2021
Figure 41. Anemia
Figure 42. Hematopoietic Growth Factor Disorder
Figure 43. Other
Figure 44. World Hematopoietic Agents Production Market Share by Application (2017-2028)
Figure 45. World Hematopoietic Agents Production Value Market Share by Application (2017-2028)
Figure 46. World Hematopoietic Agents Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Hematopoietic Agents in 2021
Figure 48. Manufacturing Process Analysis of Hematopoietic Agents
Figure 49. Hematopoietic Agents Industrial Chain
Figure 50. Distribution Channel Breakdown for Hematopoietic Agents Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
